Inici › Melanoma › Virgínia › Arlington
Assaigs clínics de Melanoma a Arlington, VA
20 estudis de Melanoma busquen participants en centres de Arlington i voltants (en un radi d'uns 30 milles). Obre un estudi per veure qui hi pot participar i com contactar amb l'equip.
Text oficial de l'estudi (anglès)
A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors
ReclutantFase 1
- Inova Schar Cancer Institute, Fairfax · a 11 mi
- NEXT Virginia, Fairfax · a 11 mi
Phase 1 Study of PF-08046033 in Advanced Solid Tumors
ReclutantFase 1
- Inova Schar Cancer Infusion Pharmacy, Fairfax · a 11 mi
- Inova Schar Cancer, Fairfax · a 11 mi
A Clinical Study of Intismeran Autogene (V940) and Pembrolizumab (MK-3475) in People With Melanoma (V940-012/INTerpath-012)
ReclutantFase 2
- Inova Schar Cancer Institute ( Site 4046), Fairfax · a 11 mi
BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study
ReclutantFase 2
- Inova Fairfax Hospital, Falls Church · a 4 mi
- Inova Schar Cancer Institute, Fairfax · a 11 mi
- Inova Fair Oaks Hospital, Fairfax · a 11 mi
A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head)
ReclutantFase 3
- Inova Schar Cancer Institute, Fairfax · a 11 mi
Study of AMXT 1501 and DFMO in Combination With Standard Therapies in Advanced Solid Tumors
ReclutantFase 1/2
- Virginia Cancer Specialists-Fairfax, Fairfax · a 11 mi
A Study to Evaluate KIN-2787 in Participants With BRAF and/or NRAS Mutation Positive Solid Tumors
ReclutantFase 1
- Virginia Cancer Specialists, Fairfax · a 11 mi
Project: Every Child for Younger Patients With Cancer
ReclutantEstudi observacional
- Inova Fairfax Hospital, Falls Church · a 4 mi
A Study to Investigate Safety of AZD6750 in Adult Participants With Select Advanced or Metastatic Solid Tumors
ReclutantFase 1/2
- Research Site, Fairfax · a 11 mi
A Study to Evaluate ARV-6723 Alone and With Pembrolizumab in Participants With Advanced Solid Tumors
ReclutantFase 1/2
- Clinical Trial Site, Fairfax · a 11 mi
A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)
ReclutantFase 1/2
- Virginia Cancer Specialists, Fairfax · a 11 mi
Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS
ReclutantFase 1/2
- Next Oncology Virginia, Fairfax · a 11 mi
A Study to Investigate the Safety and Efficacy of NST-628 Oral Tablets in Subjects With Solid Tumors
ReclutantFase 1
- NEXT Oncology - Virginia, Fairfax · a 11 mi
A Phase 1 Study of JMT108 in Participants With Advanced Solid Tumors
ReclutantFase 1
- NEXT Virginia, Fairfax · a 11 mi
Study to Evaluate LB-LR1109, Administered Alone for the Treatment of Solid Tumor and in Combination With Atezolizumab for the Treatment of NSCLC
ReclutantFase 1
- NEXT Oncology, Fairfax · a 11 mi
A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors
ReclutantFase 1/2
- Research Site 102, Fairfax · a 11 mi
- Research Site 112, Fairfax · a 11 mi
A Clinical Study of Intratumoral MVR-T3011 (T3011) Given as a Single Agent and in Combination With Intravenous Pembrolizumab in Participants With Advanced or Metastatic Solid Tumors
ReclutantFase 1/2
- Virginia Cancer Specialists, Fairfax · a 11 mi
A Study of GV20-0251 Monotherapy and GV20-0251 in Combination With Pembrolizumab in Participants With Solid Tumor Malignancies
ReclutantFase 1/2
- Virginia Cancer Specialists, Fairfax · a 11 mi
A Study of OR502, a Monoclonal Antibody Targeting LILRB2, Alone and in Combination With Anticancer Agents
ReclutantFase 1/2
- NEXT Virginia, Fairfax · a 11 mi
A First-in-human, Phase I, Open-label, Multicenter Study of NM1F(Anti-PVRIG) in Patients With Advanced Solid Tumors
ReclutantFase 1
- Next Oncology, Virginia Cancer Specialists, Fairfax · a 11 mi
Assaigs de Melanoma en altres ciutats
- Houston, TX59 estudis
- New York City, NY38 estudis
- Los Angeles, CA34 estudis
- Nashville, TN33 estudis
- Pittsburgh, PA31 estudis
- Boston, MA26 estudis
- Philadelphia, PA23 estudis
- San Francisco, CA22 estudis
- Durham, NC21 estudis
- Atlanta, GA21 estudis
- St. Louis, MO21 estudis
- Salt Lake City, UT21 estudis
Altres estudis a Arlington
- Càncer de pulmó de cèl·lules no petites104 estudis
- Càncer metastàtic53 estudis
- Càncer colorrectal52 estudis
- Càncer (tots els tipus)48 estudis
- Càncer de mama46 estudis
- Càncer d'ovari46 estudis
- Càncer de pulmó41 estudis
- Càncer d'endometri39 estudis
- Càncer de pàncrees33 estudis
- Carcinoma de cèl·lules escamoses de cap i coll26 estudis
- Càncer de pulmó de cèl·lules petites23 estudis
- Càncer de mama triple negatiu20 estudis
De ClinicalTrials.gov, dades recuperades el 5 d’oct. 2026. Cada estudi estableix els seus propis criteris d'elegibilitat; l'equip de l'estudi decideix qui hi pot participar.